Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Access Bio Inc announces merger of subsidiaries


Monday, 2 Dec 2013 07:03pm EST 

Access Bio Inc:Says the company's wholly owned subsidiary, Access Bio Korea, merged with its wholly owned subsidiary, a Korea-based company engaged in the research and development of bioscience field, and distribution of equipment.Says merger effective date of Nov. 30. 

Company Quote

10850.0
550.0 +5.34%
26 Dec 2014